Investment Pitches

Pitch Summary:
@Premski_SGP outlines a bullish case for NextVision (NXSN), an Israeli manufacturer of stabilized EO/IR camera payloads used on military drones. The author highlights validation from Anduril, which uses NXSN sensors and prefers them over U.S. alternatives due to lower weight and lower cost. He emphasizes the advantage of a supply chain with no Chinese components, a key requirement for many defense buyers. European defense procurement is increasingly specifying “ITAR-free” systems, giving NXSN an edge thanks to faster export permitting and compatibility with the sub-25kg drone category dominating new tenders. Management is praised for long-term orientation, consistent pricing, and maintaining high gross margins above 65%. Looking ahead, the author sees multiple catalysts: expanding demand driven by modern warfare, possible NASDAQ uplisting, increased visibility from Anduril’s IPO, and potential U.S. manufacturing capacity. All together, he views NXSN as a strongly positioned growth story in the defense drone ecosystem.

BSD Analysis:
NextVision operates in a structurally expanding niche of EO/IR payloads where miniaturization, weight efficiency, and export-regime flexibility meaningfully differentiate suppliers. Its positioning outside ITAR provides a durable competitive advantage in Europe, where procurement cycles increasingly demand regulatory agility as much as raw performance. The firm’s integration into Anduril’s ecosystem suggests strong product-market fit and improves long-term credibility with NATO-aligned militaries. High gross margins and disciplined pricing imply solid pricing power for a hardware-software hybrid offering in a market where reliability is mission-critical. However, customer concentration risk is material if a small set of drone manufacturers represent the majority of revenue. Regulatory dynamics—Israeli export controls, evolving European drone standards, or U.S. geopolitical pressure—remain non-trivial risks. Nonetheless, NXSN could compound earnings rapidly if defense modernization budgets remain elevated, especially as drone warfare shifts from experimental to standardized across multiple theaters.

Actual Post Content:
$NXSN: Why I like it and why I'm increasing my position: 1) Anduril offers NXSN cameras in their drones, validating their quality and performance. You can get a payload from an American manufacturer, but it's slightly heavier and 25% more expensive. 2) Sourcing / Supply Chain has no Chinesse components, which is one of the requirements when drone manufacturers are looking for cameras. 3) Growing TAM in general which I see everytime I go to Ukraine or everytime i am checking updates from the war from Polish OSINT sources, more info: 4) Competitive Edge in Europe: - European buyers have started writing “ITAR-free only” into tenders to avoid that leash; the German rifle competition is the textbook example this leads to: - Faster lead times & admin. Israeli export permits are typically 30–45 days versus 90+ days for ITAR licences. - Fits <25kg requirements that dominate new EU drone procurements. 5) Management: - they have a clear plan on how to grow the company and what products to release to market - they care about stickiness they have not raised prices in last 5 years (!) - they keep very high gross margin despite no price hikes “We’ve been consistent. Even 65% is excellent. We see no reason to expect any deterioration.” ⁃ No sugarcoating it (“AI is a buzzword” , “We all want the war in Ukraine to end. But that won’t mean drones will start dropping candy and flowers over borders” ) 6) Summary: The company has strong tailwinds: - Growing TAM, with the European market open for capture. - Anduril's IPO will boost exposure, as their drones use Next Vision. - NXSN may uplist to NASDAQ, remaining largely unknown to investors. - A US plant may be built if needed.

URL: https://x.com/premski_sgp/status/1935589366220697806

Pitch Summary:
Pitney Bowes, post the 2024 exit of its cash-burning Global E-Commerce unit, is now a two-segment company—Presort and SendTech—producing ~$2B TTM revenue and ~$525–575M EBITDA with structurally high free cash flow. Presort holds ~25% share in U.S. mail sortation (next competitor ~2%), generating ~32% EBITDA margins on a service with durable, sticky enterprise workflows (e.g., large payor/claims mailings) despite secular mail decline. The crown jewel is SendTech, a near-monopoly (~70% share) USPS-authorized metering/financing platform with equipment leasing, SaaS, supplies, and an embedded bank (Pitney Bowes Bank) that intermediates postage payments and offers revolving credit. PB Bank’s low-cost deposits drive exceptional returns (TTM NI ~$50M on ~$62M average equity, ~80% ROE), and leases migrated onto the bank’s balance sheet further monetize that funding advantage while freeing corporate cash. Companywide cost actions (now guided to $180–200M) and the e-commerce divestiture flipped a declining EBITDA profile into a cash cow with reiterated FY25 FCF of $330–370M (~$1M/day). At ~$10–11, shares trade around ~5.4× levered FCF (≈18–20% yield) and ~7.5× TEV/EBIT, unusually low for a dominant, regulated-gatekeeper franchise with recurring revenues. Governance/capital allocation is a key upside lever: activist-turned-CEO Kurt Wolf (largest holder) has authorization to repurchase $150M in 2025 and, after reaching the 3.0× leverage threshold (now expected by 2Q vs prior 3Q), gains greater flexibility to expand buybacks. Simple buyback math (e.g., $400M over two years at ~$12) could shrink the float ~18%, lifting FCF/share >20% even if aggregate FCF is flat; multiple normalization to 7–8× FCF implies $16.5–$19 plus dividends. The moat is reinforced by USPS licensing (only four authorized meter providers) and switching frictions across installed devices, workflows, and payments rails; no rational entrant targets a shrinking but high-ROIC niche with a dominant incumbent. Risks include single-B credit ratings and 2027–2029 maturities, and execution by a first-time public-company CEO; mitigants are strong FCF coverage, improving leverage, and aligned incentives (low salary, option strikes at $12/$14/$16). Net-net, this is a cash compounding, buyback-driven re-rating story with downside cushioned by monopoly-like economics and upside from capital deployment and moderate multiple expansion.

BSD Analysis:
Bull: 20% FCF yield; dominant share; bank ROE ~80%; cost-out tailwind; leverage to <3× unlocks larger buybacks; aligned CEO-owner. Skeptic: Secular mail decline; single-B credit & refi cadence; operator learning curve; regulated counterparty (USPS). Differentiator: Unique payments/lease flywheel + USPS gatekeeping + bank funding advantage create a hard-to-replicate, cash-rich platform.

Pitch Summary:
The author presents a bearish short thesis on Medifast, arguing that the company’s weight-loss meal-plan business model has been structurally impaired by the rise of GLP-1 drugs, which offer greater efficacy at significantly lower cost once insurance coverage is factored in. Management is criticized for denying the deterioration in fundamentals and for making a poor capital allocation decision by investing $30 million in LFMD without receiving any referral economics. Revenues are now falling roughly 30% per quarter, and SG&A has exceeded gross profit, suggesting the business could soon begin to burn cash despite having fixed-income assets that temporarily mask the decline. The author estimates an economic liquidation value of roughly $9–11 per share after adjusting for asset quality, payables, PP&E realizable value, and contractual obligations. Given the accelerating decline and potential negative operating leverage, he argues the stock has 30% downside with essentially no upside unless acquired at a discount by private equity. He maintains the short position expecting further deterioration.

BSD Analysis:
Medifast faces an existential challenge as GLP-1 adoption structurally reduces demand for traditional diet programs, particularly those with higher price points like OPTAVIA. The business’s MLM-driven distribution model becomes increasingly fragile as customer acquisition costs rise and product-market fit erodes. Unlike peers with diversified wellness portfolios, MED remains heavily concentrated in a category undergoing rapid disruption, which compresses both volumes and pricing power. While the balance sheet remains net cash positive, the asset mix—fixed income securities and low-value PP&E—offers limited protection against long-term cash burn as operating deleverage accelerates. Without a viable turnaround strategy or business pivot, the equity resembles a shrinking liquidation stub rather than a going concern. Regulatory or reimbursement shifts could introduce uncertainty into GLP-1 economics, but those risks skew against MED, as broader insurance coverage would accelerate substitution. In the absence of new revenue engines, MED remains a value trap with asymmetric downside.

Actual Post Content:
$MED Short -- PT 9.5/sh 30% downside, 0% upside. Decent short here because of the 0% upside -- it's not a net net yet! Everyone knows the story. CEO in denial about impact of GLP-1s on the business. Tries to fix it, invests in $LFMD, turns out to be a massive error. Keeps denying things are worsening, either lying or doesn't understand his own business -- both scenarios are bad. The core business of selling weight-loss meal plans for $400/month as a multi-level-marketing business is especially dead now that insurance covered GLP-1s would cost a fraction of that (with insurance) and would be more effective. There is no future in this business and will probably end up in bankruptcy, like Jenny Craig did a few years ago. Also the capital allocation decisions have been value destroying. Not only did $MED pay $LFMD $30m, but $MED doesn't even get a referral fee when recommending their customers to $LFMD. MED get's a small benefit from their equity in LFMD, but that's it. So now revenues are dropping 30% each quarter, and SG&A exceeded gross profits in 1Q25. But because they have 71m in fixed income assets that yield around 5m a year that are not burning much cash. But that could collpase soon because they have some fixed over-head corporate costs and marketing/advertising spend can't turn off immediately. COGS is also partly fixed with a lot of inventory already finished. We could see cash burn starting soon. Over a year they could burn 5-10m easily. They don't have any debt but they have a large payables expense and they don't have any receivables. A look at the balance sheet I estimate actual liquidation value to be around or about 11/sh, which is lower than their net cash of about 13/sh: 1. Net cash and E's: 165m (73m fixed income, 92m cash). However the 73m has an after-tax value of lets say 60m. So really this is worth 152m 2. Accounts payable: 56.5m 3. PP&E: 37.5m but only 21m is worth anything (buildings) Funnily enough they have 29m in gross software capital included for this line item. 4. 27.5m in contractual obligations (leases + inventory) Total Assets: 152+21 = 173 Total Liabilities: 27.5+56.5=84m Liquidation value = 90m. Let's say 110m in case i missed something important. This about $10/sh. By end of 2025, they might burn another 10m, or who knows how much, if things keep getting worse. So that's how I get to 9/sh or about 100m liqudiation value. Upside? I bet private equity gives 0 terminal value to the meal-plan business. and they want to buy at a discount of let's say 15% to NPV of 110m. That gives a buyout price target of around 93m or 8.5/sh. Do with that what you will. I'm holding the short for more juice.

URL: https://x.com/Fierce__beast/status/1935331296667922474

Pitch Summary:
Chime Financial is a U.S. neobank serving 8.6M monthly active members focused on sub-$100k earners, monetizing primarily through debit and credit interchange fees rather than interest income or traditional banking fees. After IPO’ing at $27/share in June 2025 (valued at ~$11.4B EV), Chime opened at $43 and settled around $31.65, amid broader fintech volatility. Its 2025 Q1 revenue run-rate was $2.1B (+32% YoY), largely driven by debit interchange (55% of revenue), with growing contributions from credit cards and lending products (24% of revenue, +57% YoY). Chime’s value proposition lies in its fee-free, mobile-first banking experience, enabling low-cost customer acquisition (50%+ organic adoption) and 67% primary account penetration—key to layering higher-margin services like MyPay (earned wage access) and Instant Loans. Its cost-to-serve advantage ($152 vs. $450–$740 for traditional banks) underpins structural profitability as it scales, while brand power and satisfaction drive 104% transaction profit retention. The company targets 22% revenue CAGR to $5.6B by 2030, with user growth from 8.6M to 18.8M and ARPAM rising to $299 (+6% CAGR). Modeled net income margins expand from 2% in 2025 to 21% by 2030, implying ~26% operating margins and ~29% Adjusted EBITDA margins. The base case valuation assumes a 25× PE multiple on 2030 earnings, yielding an 18% 5-year IRR and ~$73/share price target. Key risks include potential Durbin Amendment repeal (which could reduce debit interchange rates by 25%), macro sensitivity of its low-income demographic, and intensifying fintech competition (SoFi, Block, PayPal, Affirm). Nonetheless, Chime’s depository “anchor” gives it a durable moat versus fintech peers building from non-core products. Regulatory dependence remains its largest tail risk, though mitigated by political difficulty of repeal and Chime’s diversified revenue mix. Near-term catalysts include its first public earnings call (fall 2025) and continued ARPAM expansion via new product rollouts.

BSD Analysis:
Bull: 32% growth, 104% retention, cost advantage, scalable brand, underpenetrated TAM, path to 20%+ net margins. Skeptic: Durbin risk, fintech competition, low-income exposure, limited profitability history. Differentiator: Scale moat via primary deposit control + unit economics discipline unlike smaller neobanks.

Pitch Summary:
The author argues that ZipRecruiter faces accelerating deterioration in fundamentals despite a relatively stable macro hiring environment and healthy performance from competitors like LinkedIn and Indeed. Declining traffic at third-party job sites weakens ZIP’s value proposition, reducing click-through activity, pricing power, and customer retention. Meanwhile, employer counts continue to fall, and revenue per employer has begun contracting as the company runs into pricing elasticity limits and competitive pay-for-results models gain share. This double pressure has caused EBITDA margins to collapse from 17% to 5%, with revenue down double digits while SG&A remains fixed. The author disputes consensus expectations for a 2026 revenue rebound, suggesting ZIP will continue to lose share as AI-driven resume screening reduces the need for niche job boards. Applying a 12× multiple to an estimated $30M in 2026 EBITDA yields fair value near $3 per share—roughly 45–50% downside.

BSD Analysis:
ZipRecruiter operates in a structurally challenged segment of online recruiting where aggregator-style job boards are losing leverage to ecosystem giants like LinkedIn, Indeed, and enterprise ATS platforms. The industry is consolidating toward pay-for-results models, diminishing the appeal of ZIP’s flat-fee subscription pricing. Moreover, AI adoption materially shifts value away from curated job boards, as enterprise customers increasingly rely on automated applicant filtering rather than specialized funnels. ZIP’s dependence on external traffic partners introduces fragility, especially as many of these sites show declining engagement. The margin profile suggests ZIP lacks operating flexibility: with limited variable cost levers, even modest revenue stagnation results in rapid EBITDA compression. While the balance sheet has historically offered a cushion, sustained revenue declines could force incremental marketing spend to preserve relevance, worsening unit economics. Structural threats appear secular rather than cyclical, making a valuation compression plausible as the business transitions from a growth narrative to a cash-harvesting decline. In this context, the author’s downside case aligns with broader ecosystem trends.

Actual Post Content:
Short $ZIP PT $3/sh, downside 45%. $ZIP is not thematically a short like $TTGT which is facing declining web traffic and thus lower advertising revenues, but there are some overlaps. The more troubling issue with $ZIP is that fundamentals continue to deteriorate at a rapid pace at the same time that Linkedin, Indeed, and unemployment rates have not: 1) web traffic declines at partner sites like Dice.com or Recruiter.com should negatively impact ZIPs customer click through rates, and thus will put pressure on $ZIPs value add (driving job applications) and this should negatively impact churn and pricing power going forward. I looked at some of ZIPs largest recruitment partners like Jooble, Talent.com, MyJobhelper.com, lensa.com, Simplyhired.com and the trends don't look good. Check for yourself but web traffic is down for all of them over the last 5 quarters except lensa. 2) $ZIP asks for a flat-fee subscription, but competitors like Linkedin ask for Pay-for-results. Also, with AI resume screeners, you don't need a curated recruitment platform (like WayUp or Dice) that specialize in a specific domain, now your AI screener goes through all the linkedin applications and selects the ones you need to review. 3) Employer count keeps sliding. QPE is still –11 % YoY despite a seasonal Q1 rebound, signalling that more SMBs are churning off the platform than joining it. 4) Prices hit an elastic ceiling. $ZIP lifted RPE for four straight quarters to offset churn, but once rivals’ pay-for-apply options gained traction the metric dropped 10 % QoQ in Q1-25. 5) Margins collapse when both levers break. With QPE down and RPE now falling, revenue is –10 % YoY while SG&A dollars barely move; operating leverage flips and adj. EBITDA margin has cratered from 17 % to 5 % in a year. 6) There has been a slight decline in BLS JOLTS hires rate. However, the ZIP data is much worse, indicating that this is a company specific issue. For example, 1Q25 QPE would have been 68.2k if it tracked JOLTs data but instead it was 63.5k. 7) Valuation and consensus estimates. $ZIPs valuation is 21.5x ev/NTM EBITDA -- that's about the highest it has been since peak 2021 when the outlook was high growth. It's unclear to me why consensus estimates expect revenue growth in 2026. Do they think that $ZIP will suddenly become competitive vs Linkedin's pay-for-results GTM strategy or that AI resume scrapping will become less useful? Or do they think that web traffic will return back to ZIPs partner websites? EBITDA margins collapsed to 5% in 1Q25 vs 17% in 1Q24 and 13% in 4Q24. This is due to a drop in customers from 71.6k to 63.5k at the same time that SG&A has not declined at all. I worry that as website traffic declines and re-routes to a select few publishers, ad spending expenses for $ZIP and many other tier 2/3 types of business could explode in terms of competitiveness. The reality is that probably they won't explode but certainly i see this expense line item being pressured for a while. It won't bode well for $ZIPs bottom line and EBITDA margin goals. I expect continued misses and negatie estimate revisions for this business as well as a valuation multiple re-rate once the market realizes that EBITDA will not V shape back to a higher level, but instead will continue worsening or stagnate at this low level on declining to flat revenue growth. There is no way that it should trade at 22x forward EV/EBITDA with this profile. I think EBITDA in 2026 will maybe be around 30m and I think 12x ebitda is the appropriate multiple to give to this type of business. We're talking about a 360m EV, 540m in debt and 470m in cash&equivalents and 98m diluted shares oustanding. I'm looking at a 2.9/sh stock, almost 50% downside from here.

URL: https://x.com/fierce__beast/status/1934786323186843826

Pitch Summary:
VICI Properties is the dominant gaming REIT in the U.S., owning trophy assets across the Las Vegas Strip including Caesars Palace, The Venetian, and MGM Resorts. The company operates under a triple-net lease (NNN) model, meaning tenants cover maintenance, insurance, and taxes—providing VICI with predictable, inflation-protected cash flows. Las Vegas assets make up 83% of annual rent, supported by 100% occupancy and long-term 40-year leases, with 90% of rents CPI-linked by 2035. VICI owns 660 acres, 41,400 hotel rooms, and 5.9 million square feet of convention space, benefiting from Las Vegas’ post-pandemic resurgence (42M visitors and $8.5B in gaming revenue). Management targets AFFO and dividend growth, emphasizing accretive acquisitions rather than aggressive expansion. The dividend has compounded at 7.4% CAGR since inception and currently yields ~5.4%, while AFFO grew 5.6% YoY last quarter. Leverage remains stable at 5.3× EBITDA, and management guides for 2025 AFFO of $2.35/share, implying a 12.9× forward P/AFFO—below historical 16–17× levels. Viewed as a bond proxy for investors seeking 5–8% total returns with limited downside, VICI’s high-quality, CPI-protected leases offer resilience even in macro volatility. Risks include Vegas concentration and interest-rate sensitivity, but underlying real estate remains irreplaceable, with strong tenant quality and embedded rent escalations. Catalysts include lower treasury yields driving multiple expansion back to ~15× AFFO and incremental rent growth from tenant renovations (Venetian $1.5B, Caesars $435M). The idea: steady, low-risk income growth and optional upside if rates fall—VICI is “the house behind the house.”

BSD Analysis:
Bull: CPI-linked leases, stable tenants, 100% occupancy, 5.4% yield, AFFO growth, lower interest-rate sensitivity vs peers. Skeptic: Limited organic growth, Vegas concentration, “bond-like” return cap, reliant on macro tailwinds. Differentiator: Only pure-play Strip REIT with inflation-protected rent escalators and fortress balance sheet.

Pitch Summary:
Following the July 2024 merger of Six Flags and Cedar Fair, “FUN” is now the largest amusement park operator in North America, controlling 42 parks across the U.S., Canada, and Mexico. The Cedar Fair management team now runs the combined entity, bringing operational excellence to historically mismanaged Six Flags assets. The pitch argues the stock’s decline to ~$29.50 (from $57) reflects weather disruptions and unfounded consumer demand fears, not fundamentals. The industry’s barriers to entry are enormous—no new major parks have been built outside Orlando/LA in decades, while land, permitting, and NIMBY constraints have only grown. The legacy Six Flags parks are materially under-earning, with attendance still 10M below 2019 levels and guest revenue ~$30/day below Cedar Fair’s. Under Cedar Fair’s proven management, the turnaround focuses on clean parks, shorter lines, digital modernization, and improved food/service, which historically drove double-digit returns elsewhere. Management is targeting $120M+ in merger synergies (ahead of schedule, possibly +$60M more in 2026) from organizational streamlining, procurement, and unified tech and marketing platforms. The author models attendance recovery + pricing power as the core upside drivers—adding 7–15M visitors could yield $750M–$1B incremental EBITDA by 2028–2030. The stock’s 2025 P/E (17.7×) and EV/EBIT (18×) are depressed versus normalized 9–11× EBITDA peers, offering asymmetric upside if execution and weather normalize. Longer term, the author sees potential for $1.8B+ EBITDA by 2030, implying a multi-year compounder as the market re-rates. Risks include weather, macro-driven demand dips, and integration execution—but the moat, management credibility, and upside outweigh near-term noise.

BSD Analysis:
Bull: Largest U.S. park portfolio, irreplicable assets, proven new management, under-earning base, weather-related overreaction, high EBITDA leverage. Skeptic: High capex, integration risk, macro/consumer exposure, slow recovery timeline. Differentiator: Massive embedded earnings power with no new competition, underpriced for scale and management quality.

Pitch Summary:
LENSAR is a merger-arbitrage setup with a kicker: Alcon agreed to acquire LNSR for $14.00 cash per share plus a $2.75 CVR tied to procedure volume, creating a “heads I win / tails I win a bit less” profile. The CVR pays if Alcon performs 614k cumulative procedures in 2026–2027, versus 169k in 2024—ambitious but plausibly achievable given accelerating placements of the ALLY next-gen femto laser, rising recurring revenue (razor/razorblade), and Alcon’s global distribution muscle. The spread widened after an FTC second request (5/22), moving the arb from a money-market-plus parking spot to a standalone opportunity; at $12.22, upside to the cash leg alone is ~14.5%, with another ~22.5% potential from the CVR (total ~37% if fully paid). Importantly, the shareholder base is dislocated: fundamental longs see capped upside, while classic arbs historically ignored the low-IRR CVR—creating no natural holder and, thus, mispricing. Governance dynamics also de-risk approval: North Run Capital controls ~45.8% voting power via a support agreement, securing the takeout price even though shares traded ~$16.50–$16.90 pre-announcement. Pre-deal, LNSR was rerating to ~4–5.5x NTM sales in line with fast-growing med-tech comps, suggesting that if the deal breaks on antitrust, the stock could trade up as fundamentals investors return. Conversely, if it closes, investors capture the cash spread soon and retain the upside CVR option; even though the CVR’s standalone IRR (~6–7% to 2028) isn’t thrilling, it’s a free option once principal is returned. Execution tailwinds include strong Q1’25 procedure growth (+33% y/y, +15% q/q), increasing unit placements, and workflow savings for surgeons that drive higher throughput and utilization. Principal risks are regulatory delays, an outright block (with potential positive equity reaction), or business slowdown that jeopardizes the CVR; near-term headline risk can pressure shares, but the current spread should attract more event-driven buyers. Net-net: a misowned, asymmetric arb with a credible industrial buyer and a CVR that could pay under a realistic (not heroic) adoption curve.

BSD Analysis:
Bull: Signed Alcon deal, strong momentum of ALLY, Alcon distribution, misowned spread, CVR aligned to tangible volume milestone. Skeptic: FTC second request, CVR requires sustained 26%+ annual procedure growth, CVR IRR modest, timing slippage. Differentiator: “No natural holder” dislocation + upside if the deal breaks as fundamental buyers re-underwrite growth at ~4–5.5x NTM sales.

Pitch Summary:
Kina Asset Management Limited offers a diversified investment portfolio with exposure to PNG, Australian, and global securities. However, the lack of unique or difficult-to-buy securities in its portfolio limits its appeal.

BSD Analysis:
Kina Asset Management Limited provides investors with a diversified portfolio, allocating 32% to PNG securities, 37% to Australian securities, and 20% to US and global securities. The firm's portfolio composition is relatively standard, with a significant allocation to banks in PNG and Australia. The net asset value per share stands at K2.01, with shares trading at a 10% discount to NAV. While this discount is modest compared to some closed-end funds, the lack of unique investment opportunities within the portfolio may deter investors seeking differentiated exposure. Kina's focus on established markets and securities offers stability but limits potential upside.

Pitch Summary:
Edenred is the largest employee benefits provider globally, connecting over 60 million users, one million corporate clients, and two million partner merchants across 45 countries. It is best known for its meal voucher programs - particularly 'Ticket Restaurant' - which originated in France in the 1960s and has since been adopted in countries such as Brazil, Italy, and Belgium. Meal vouchers allow companies to subsidize employees' meals while they are at work, representing a tax efficient way for employers to provide additional purchasing power to their workers. Employer contributions are often exempt from social security charges and taxes, the benefit is typically tax-exempt for employees, and the programs drive traffic to restaurants. Edenred's proprietary technology orchestrates the meal voucher ecosystem. The company works with employers to pre-fund employee accounts, then provides mobile payment solutions (compatible with Apple Pay and Google Pay) that allow employees to spend their vouchers. The platform enforces spending rules - ensuring funds are used only with approved merchants for eligible food-related items within daily limits – and provides comprehensive reporting to all parties. The structure of this ecosystem creates powerful network effects. Employers often prefer meal voucher issuers whose vouchers are widely accepted, maximising utility for their employees. Merchants prefer partnering with leading issuers who bring the most customer traffic. The result is market concentration: in France for example, the market has been dominated by four primary issuers for several decades, led by Edenred with >40% market share. Edenred has diversified its business beyond meal vouchers over time, to other benefit categories such as gifting and wellness, as well as fuel/toll cards and corporate payments. As a result, meal vouchers now represent ~40% of its operating revenue. At the same time, its organic growth has compounded at ~10% p.a. over the past 15 years, including ~14% p.a. over the last five years, as governments globally have inflation-adjusted their tax-free meal voucher spending limits, highlighting the resiliency of its business model to inflation. Its earnings similarly grew at a ~10% compound rate over this period. However, the company's significant market power and critical role in the administration of meal vouchers, together with its take-rate based business model, have increasingly exposed it to criticism and regulatory risk. This risk has been particularly heighted over the past two years, as high inflation has prompted governments to scrutinise intermediaries perceived as contributing to rising food costs. The company has faced government inquiries in its three largest meal voucher markets - France, Italy, and Brazil - which together represent ~30% of operating revenue. In 2024, the Italian government introduced a 5% fee cap on meal voucher take-rates in response to lobbying from merchants. This measure is expected to reduce EBITDA by ~9%. France has recently proposed legislative changes of its own, which we expect to have a relatively neutral impact on the company in their current form, while Brazil's inquiry remains ongoing. Notwithstanding the relatively modest financial impact to date, these inquiries have dramatically impacted investor sentiment, with Edenred's forward PE ratio falling from ~30x in the five years to June 2023 to ~10x today. When we initiated our position in the company, it was trading at ~17x forward earnings, which we felt represented adequate compensation for the regulatory risks. Given today's greater clarity around likely regulatory outcomes, and the lower share price, we believe we have a high probability of generating strong returns on the position. This positive asymmetry in the return outcome is critical, as we are typically very hesitant to take regulatory and litigation risk, given their inherent uncertainty.

BSD Analysis:
The manager presents Edenred as a global leader in employee benefits with powerful network effects and defensive characteristics, despite facing regulatory headwinds. The company operates the world's largest employee benefits ecosystem connecting 60 million users, one million corporate clients, and two million merchants across 45 countries. Edenred's competitive moat stems from network effects in meal voucher programs where employers prefer widely-accepted vouchers and merchants prefer issuers with high customer traffic, creating market concentration with Edenred holding over 40% share in France. The business model benefits from tax-efficient structures that drive adoption and inflation-indexed government spending limits that provide natural growth. The company has demonstrated resilience with 10% annual organic growth over 15 years and successful diversification beyond meal vouchers to 40% of revenue. However, regulatory scrutiny in key markets (France, Italy, Brazil) representing 30% of revenue has created investor concern, with Italy's 5% fee cap expected to reduce EBITDA by 9%. The manager views current 10x forward PE as creating positive asymmetry given greater regulatory clarity and modest financial impact to date.

Pitch Summary:
Dollarama was the largest contributor to the Fund's FY25 performance. The company operates the largest dollar store chain in Canada with over 1,500 stores - six times more locations than its nearest competitor. It sells general merchandise, consumables, and seasonal items up to $5. Unlike US dollar stores that primarily serve lower-income customers, Dollarama appeals to a broad demographic, using multiple price points to maintain affordability for core customers while attracting higher-income shoppers. This strategy has delivered remarkable consistency, with revenue growth averaging 11% p.a. over the last 15 years without a single down year. Dollarama is also highly profitable, achieving operating margins of 26.7%, more than triple its peers, with the difference owing to high private-label penetration (~70%), direct sourcing relationships, and operational efficiency. The company manages its $40 billion enterprise with just 650 head office employees, while the CEO and VP spend three days weekly visiting stores. FY25 represented another period of relentless execution for Dollarama, with same-store sales growing ahead of expectations. Sentiment towards the stock has improved as Canadian economic weakness drove increasingly value-conscious consumers to the business. During the year, Dollarama also expanded its international strategy, announcing a planned expansion of its successful Latin American JV into Mexico and the acquisition of The Reject Shop in Australia - which extends its runway for growth. While Dollarama's quality is high, its recent share price performance has rendered its valuation less compelling than at the start of the year. Consequently, we have steadily reduced our position, recycling the proceeds into more compelling opportunities. We are deliberately slow to reduce positions in high quality companies on valuation grounds, because valuation is not an exact science, and quality companies often deliver positive surprises.

BSD Analysis:
The manager presents Dollarama as a dominant Canadian retailer with exceptional operational metrics and consistent execution. The company's competitive moat stems from its massive scale advantage with over 1,500 stores versus competitors, creating six-times the footprint of its nearest rival. Dollarama's differentiated strategy targets a broader demographic than typical dollar stores, using multiple price points to serve both value-conscious core customers and higher-income shoppers seeking convenience. The company's financial profile is exceptional with 26.7% operating margins - more than triple peer levels - driven by 70% private-label penetration, direct sourcing, and remarkable operational efficiency managing a $40 billion enterprise with only 650 head office employees. The investment thesis is supported by 15 years of consistent 11% annual revenue growth without a single down year, demonstrating resilience across economic cycles. Recent performance benefited from Canadian economic weakness driving increased consumer value-seeking behavior, while international expansion into Mexico and Australia acquisition extends the growth runway.

Pitch Summary:
The largest negative impact on the Fund in FY25 came from Icon, a top-tier global clinical research organisation (CRO). Icon saw a 25% reduction in consensus 2027 EPS estimates during the year, and a more than 50% decline in its stock price, building on the challenges we outlined in our 2025 half-year investor letter. In our view, its currently depressed valuation reflects one of two market narratives: either investors believe the reduction in R&D spending by pharma companies in recent years is permanent, thereby limiting Icon's future growth potential, or more likely, the market sees no immediate growth catalysts and views the stock as 'dead money' in the near term. With the stock trading at a 10% free cash flow yield, we consider the downside risk limited and are content to be patient.

BSD Analysis:
The manager maintains a patient, contrarian stance on Icon despite significant fundamental and stock price deterioration during FY25. The company experienced a 25% reduction in consensus 2027 EPS estimates and over 50% stock price decline, reflecting broader challenges in the CRO industry. The manager identifies two potential market narratives: permanent reduction in pharma R&D spending limiting future growth, or temporary headwinds with no immediate catalysts creating a 'dead money' perception. The investment thesis relies on Icon's quality as a top-tier global CRO and attractive valuation metrics, with the stock trading at a 10% free cash flow yield. The manager's neutral stance reflects confidence in limited downside risk at current valuations while acknowledging uncertainty around timing of recovery. This represents a classic value investing approach of maintaining positions in quality companies during cyclical downturns.

Pitch Summary:
Wise is the largest non-bank FX transfer service globally, with a Founder-led dedication to lowering fees on cross-border transactions. It has grown strongly for years as consumers and small businesses have gravitated to its attractively priced, convenient, fast, and transparent transfer offering. However, Wise's ultimate goal is to replace the aging financial plumbing that banks use to facilitate currency transfers, a market multiples the size of the consumer market. During FY25 Wise saw several large legacy banks adopt its B2B service, increasing the likelihood of it achieving this long-term goal.

BSD Analysis:
The manager presents Wise as a disruptive force in cross-border payments with significant expansion potential beyond its current consumer base. The company has established market leadership in non-bank FX transfers through founder-led focus on fee reduction and service quality. Wise's competitive advantages include attractive pricing, convenience, speed, and transparency that have driven consistent growth as customers migrate from traditional banking solutions. The key investment thesis centers on Wise's ambitious goal to replace legacy banking infrastructure for currency transfers, representing a total addressable market significantly larger than the current consumer segment. The validation of this strategy came during FY25 with adoption by several large legacy banks of Wise's B2B services, providing proof of concept for the infrastructure replacement thesis and increasing confidence in the company's long-term growth trajectory.

Pitch Summary:
Visional is the leading anonymous professional job matching service in Japan. It operates a reverse-search model, where professionals create searchable profiles while maintaining privacy until they choose to engage with potential employers or headhunters. Visional has a leading share in a secularly growing market. Traditionally, Japanese professionals have remained employed by the same company for the long-term, with far less mid-career mobility than in other developed markets. This is now changing as Japan's declining population creates labour shortages and accelerating corporate transformation demands more dynamic workforce management, driving more frequent job changes and higher wages.

BSD Analysis:
The manager identifies Visional as a beneficiary of structural changes in Japan's labor market dynamics. The company's competitive advantage lies in its unique reverse-search model that preserves professional privacy while enabling efficient job matching. Visional holds a leading position in what the manager characterizes as a secularly growing market driven by demographic and economic forces. Japan's declining population is creating labor shortages that necessitate more efficient talent allocation, while corporate transformation initiatives require more dynamic workforce management. These trends are breaking down traditional Japanese employment patterns of lifetime employment, creating increased mid-career mobility and wage growth. The convergence of demographic pressures and corporate modernization creates a powerful secular tailwind for Visional's platform.

Pitch Summary:
Heico develops and sells aircraft parts that serve as alternatives to the expensive parts sold by original equipment manufacturers. Its non-original parts continue to take share of the total parts market due to their high quality and low prices – the latter maintained even as original part competitors price rapaciously. Strong demand from commercial airlines, coupled with optimism around higher defence spending and greater government efficiency, lifted Heico's sales and earnings growth outlook during FY25.

BSD Analysis:
The manager presents a compelling bull case for Heico based on its competitive positioning in the aircraft parts aftermarket. The company's value proposition centers on providing high-quality alternatives to expensive OEM parts while maintaining pricing discipline even as competitors raise prices aggressively. This strategy has enabled Heico to gain market share in the total parts market. The investment thesis is supported by multiple tailwinds including strong commercial airline demand recovery and anticipated increases in defense spending. The manager's optimism about greater government efficiency suggests potential for improved defense procurement processes that could benefit Heico. The combination of market share gains, pricing power, and favorable end-market dynamics positions Heico for accelerated sales and earnings growth.

Pitch Summary:
To capitalize on these market dynamics, we invested in First Industrial Realty Trust (NYSE: "FR"), a U.S.-only, internally-managed, mid-capitalization REIT. First Industrial owns 424 logistics properties totaling approximately 70 million square feet in 15 markets, concentrated in supply-constrained coastal markets such as Southern California, South Florida, and New York. The company is durable: (i) its properties are the youngest among its publicly traded peers, with an average vintage of 2005; (ii) its properties feature a high average clear height of 31 feet, which is important for modern tenants who require higher clear heights to optimally stack goods for vertical efficiency; and (iii), beyond its existing assets, First Industrial possesses an enviable in-the-money land bank of approximately 1,000 acres in attractive markets that can be used develop an additional 16 million square feet. We expect the large spread between First Industrial's in-place and market rents will continue to drive strong growth in same-store net operating income (SSNOI), a real estate metric akin to EBITDA, even as re-leasing spreads tighten from highs in 2023 and 2024. Over the next five years, we project a ~7% CAGR in First Industrial's SSNOI, which will drive an even stronger ~9% CAGR in free cash flow per unit over the same period. At its current price, we believe First Industrial trades below replacement cost and at an attractive valuation of a 6.5% cap rate (2025E) / 8%+ mark-to-market cap rate. This represents a large spread, over 20%, to where other high-quality public industrial REITs and comparable private market transactions are valued. Should the construction environment improve, management can also invest in its land bank to benefit from near-term supply constraints. First Industrial's management team has a strong track record as a profitable developer. We believe an investment in First Industrial today can defensively generate a 15% IRR over the next five years. We anticipate the majority of our projected return could be realized over the next two years, as the market looks past near-term tariff noise and focuses on the compelling supply/demand environment in 2026 and beyond. As core institutional capital returns to the market after years of redemption queues, we would not be surprised to see private markets and take-private activity that highlights the value embedded in First Industrial's shares. In an upside scenario, where First Industrial's valuation normalizes against private and public peers within two years, and market rent growth accelerates due to the continued supply/demand imbalance, we project our investment can generate a 20%+ IRR. In a downside scenario, where valuations compress due to higher for longer interest rates, coupled with a cyclical softening in leasing demand, we project an ~8% IRR. Ultimately, we believe the pronounced upside/downside convexity of this investment in essential, class A logistics real estate is attractive in this market environment.

BSD Analysis:
Silver Beech Capital presents a compelling bull case for First Industrial Realty Trust, positioning it as a beneficiary of structural logistics demand amid constrained supply. The manager's thesis centers on a unique convergence of factors: prohibitive construction costs have pushed replacement rents 15% above current market levels, while new supply deliveries are projected 60% below 2022 peaks. First Industrial's portfolio advantages include the youngest properties among peers (2005 vintage), optimal 31-foot clear heights for modern logistics needs, and a valuable 1,000-acre land bank for future development. The fund projects strong fundamentals with 7% CAGR in same-store NOI and 9% CAGR in free cash flow per unit over five years. At a 6.5% cap rate, the REIT trades at a 20%+ discount to peers and below replacement cost, offering defensive downside protection with 8% IRR in bear case scenarios. The manager anticipates 15% base case IRR with potential for 20%+ returns if valuations normalize, supported by eventual private market activity and institutional capital return.

Pitch Summary:
Hoping to emulate the success of Strategy (MSTR), public companies are rushing to become holding companies for digital assets and hoping to trade at multiples of their net asset value. Why should this persist, or happen at all, when an investor could easily purchase an ETF and gain exposure to the same asset without paying a premium? It is ridiculous and everyone knows it. MSTR advances a range of fanciful explanations in its investor communications, though they no doubt understand perfectly well the root cause, which is simple. By mandate, many institutional investors who are restricted from buying digital assets or ETFs are permitted, and may even be required in some cases, to hold an "operating" company that happens to be a holding vehicle for bitcoin or another digital asset. Some subset of managers who want to invest in digital assets, but are not permitted to do so, are doing so anyway with their investors' capital through this mechanism. The availability of exit liquidity at a premium that this has created is prompting a flood of supply from digital asset sponsors, but it will take time for the new paper to fully meet demand. Children can point out that the emperor is streaking all they like, but MSTR will continue inventing new kinds of preferred stock with silly names until enough shares have been printed to overwhelm demand. We are aggressively positioned on both sides of the book to capitalize on this dynamic. While capital is flowing into these issuers, we have PIPE commitments to acquire interests at significant discounts to current trading levels. On the short side, we have structured a sizeable synthetic put position in MSTR through its convertible bonds, which will benefit from an eventual compression of the premium to NAV. The main mechanism for eliminating a premium is new supply and registration of newly issued securities, and eventually I think these issuers will all trade below NAV just like the closed-end funds they resemble. I cannot predict the timing, but the likely order of events has me optimistic we can capitalize in both directions.

BSD Analysis:
The manager presents a strongly bearish thesis on MicroStrategy (MSTR), viewing it as an overvalued bitcoin proxy trading at an unjustifiable premium to net asset value. His core argument is that MSTR exploits regulatory arbitrage, allowing restricted institutional investors to gain crypto exposure through an "operating" company structure when they cannot directly buy digital assets or ETFs. The manager believes this premium is unsustainable and will compress as new supply from copycat issuers floods the market. He criticizes MSTR's continuous issuance of preferred shares with "silly names" as dilutive capital raising that will eventually overwhelm demand. The fund has structured a synthetic short position through convertible bonds while simultaneously taking PIPE commitments in similar issuers at discounts. This pairs trade strategy positions the fund to profit from both the collapse of MSTR's premium and the initial flow of capital into new crypto treasury companies. The manager expects these vehicles will eventually trade below NAV like traditional closed-end funds.

Pitch Summary:
From 2022-2024 the fund was the largest shareholder, and I served on the board of Arca Biopharma, culminating in its merger with Oruka Therapeutics (ORKA). My short seller's jaundiced view of corporate managers and boards was softened somewhat by the experience of serving on one. Enough ink has been spilled about principal-agent problems and strategic alternatives review processes by sector specialists. In brief, I share their skepticism of reverse mergers, though I recognize that an exchange listing has value to an acquirer. I believe the ORKA transaction is a good model for similarly situated issuers: the transaction valuation should ideally be validated by concomitant financing, and the company should commit to returning most or all of its capital in connection with the transaction, ensuring an outcome superior to liquidation for shareholders irrespective of the subsequent performance of the target. In a competitive market for targets to take public, we remain involved in several ongoing processes.

BSD Analysis:
The manager presents a bullish view on Oruka Therapeutics (ORKA) based on his direct involvement as the largest shareholder and board member of Arca Biopharma through its merger with ORKA. His thesis centers on the transaction structure being a superior model for biotech reverse mergers. The manager emphasizes that the ORKA deal was properly validated through concomitant financing and included capital return commitments that ensured shareholders received value superior to liquidation regardless of future performance. This represents a disciplined approach to biotech M&A during the current downcycle. The manager's board experience provided insider perspective on the transaction's merit and execution. His continued involvement in similar processes suggests confidence in replicating this successful model. The position reflects both activist engagement and mean reversion strategies in undervalued biotech assets trading below intrinsic value.

Pitch Summary:
@Fierce__beast argues that Taboola is an attractive short because its business model is structurally tied to declining web traffic, particularly across major news and portal sites that represent a large portion of its revenue. A substantial share of its recent growth comes from the Yahoo partnership, but this deal includes a guaranteed minimum revenue-per-impression that shifts risk entirely to Taboola if ad yields fall. With Yahoo traffic down 10–15% year-over-year, the author suggests that TBLA may soon be forced to “top up” guaranteed payouts, turning a previously accretive partnership into a margin headwind. In addition, the company’s AI positioning is viewed as promotional, with no functioning product available for testing despite heavy marketing. Underlying growth excluding Yahoo contributions appears flat, calling into question the sustainability of recent results. Altogether, the author believes a combination of declining traffic, unfavorable deal economics, and reliance on fragile publisher relationships makes TBLA a compelling short.

BSD Analysis:
Taboola faces meaningful secular pressures as traditional web discovery shifts toward AI agents, chat interfaces, and platform-centric content consumption. Its exposure to large news publishers—who themselves are structurally challenged—creates a revenue base that is both concentrated and vulnerable to volume declines. The Yahoo contract, while initially celebrated, creates asymmetric downside risk through guaranteed yield floors that effectively introduce fixed obligations into a business once more variable and scalable. The company’s attempt to reposition around AI lacks demonstrated product-market fit and could reflect strategic desperation rather than innovation. As advertising continues migrating to closed ecosystems (TikTok, Meta, YouTube) and away from the open web, Taboola’s long-term earnings power becomes increasingly questionable. Without meaningful new demand sources or differentiated ad-tech capabilities, the company may struggle to offset traffic declines or margin erosion. Valuation may look inexpensive, but the business trendline could still worsen materially from here.

Actual Post Content:
$TBLA, $ZD, $TTGT, $CRTO and others that are dependent upon web traffic are probably decent shorts: One issue though, is that if all ad tech stocks face the same issue it's not like publishers have alternatives, so revenues should then decline roughly in-line with declining web traffic across the internet. $TBLA though seems very suspicious to me. The CEO is trying to pivot into 'AI' and was on CNBC last Friday dissing Perplexity. I signed up for TBLA's alternative AI solution but it's not even publicly available yet. So they are claiming their AI solution is way better, but there's no way to actually test it. Immediately I'm thinking this is a highly promotional CEO. Next, $TBLA probably has a large % of its revenues derived from news sites like CNN or NBC. Yahoo + Microsoft (MSN) made up ~32% of 2024 gross publisher revenue; the top-5 digital properties were ≈40%. All five are global news-information portals (Yahoo, MSN, NBCUniversal, Fox, Axel Springer), so at least one-third of Taboola’s revenue is tied to major news outlets alone. That is a tremendous drag on the business if indeed web traffic is declining to websites -- my best guess is a 3-5% overall revenue drag to the business. Yahoo and TBLA entered into a 30-year contract where Yahoo is paid a rev-share with a contractually defined floor (minimum revenue-per-impression). If auction yields fall below that floor, Taboola must 'top-up' the difference, so the guarantee liability sits with Taboola, not Yahoo. This could end up a disaster for Taboola because if web traffic declines, then Taboola will be stuck with a high fixed cost. I'm short $TBLA, $ZD, $TTGT, and $CRTO. Adding some info to this $TBLA short idea: The yahoo agreement date closed 1/17/2023. Full commercial ramp started in 4Q2024. The Yahoo deal began contributing meaningfully in Q4 2024 and delivered a one-time step-up in gross profit and margins, but early 2025 numbers already show that the easy growth phase is over. Taboola must keep ad yields above the contractual floor and find new demand sources to prevent Yahoo from turning from a margin booster into a margin drag. I think with the recent declining web traffic insights, the deal won't go as well as expected for $TBLA. This Yahoo deal was started at just the beginning of ChatGPT 3.0 in late November 2022. Nobody could have really understand the impact it would have on web traffic in mid-2025. adding more $tbla. Management said Yahoo contributed a 'high-single-digit' share of Q1-25 ex-TAC gross profit; taking the midpoint (≈8%) puts Yahoo at roughly $12m of the $152m reported. Strip that out and ex-TAC GP is ≈$140m versus $139m in Q1-24—essentially flat (+0–1%)—so the bulk of the headline +9% growth came from Yahoo, not the legacy network. On a GAAP-revenue basis the same adjustment turns the reported $427m (+3% YoY) into roughly $412m, again implying underlying revenue was flat to down a point without Yahoo’s lift. what have been yahoo web traffic trends? Down ~10–15% vs. a year ago. The Similarweb panel has Yahoo’s monthly visits easing from the mid-3 billions early last year to ~3.1bn today, while weekly snapshots put current traffic 13% under the April 2024 baseline. 1) asked the AIs about it but didn't verify 2) less traffic drives down value that TBLA brings, thus limiting their ability to add value and raise price. it hurts advertisers more, they need to start paying up to capture declining traffic if they want to yield the same volume if traffic wasn't declining. i just think this all circles back to being bad for tbla.

URL: https://x.com/Fierce__beast/status/1934665097403662722

Pitch Summary:
Reddit represents a multi-year compounder in digital advertising and data monetization, trading at a valuation that underappreciates its unique user-generated content (UGC) ecosystem and long runway for ARPU expansion. The platform—100M DAUs, $1.4B annualized revenue, and ~$300M pre-stock-comp FCF—has evolved from a chaotic community hub into a modern, adtech-oriented business with partnerships in AI and data licensing. CEO Steve Huffman (co-founder, YC alum) has overhauled Reddit’s ad stack and culture, hiring top META/GOOG veterans, improving targeting, and introducing new monetization levers (Reddit Premium, paywalled subreddits, creator economy tools). Reddit’s current ARPU of $14.50 is comparable to Pinterest/Snap but a fraction of Meta’s $50+, leaving clear upside through higher ad-loads, better targeting, and geographic expansion. The company’s strategic alliances with Google (API licensing, elevated search placement, GCP/LLM integration for Reddit Answers) and OpenAI (data licensing for ChatGPT) monetize Reddit’s UGC while future-proofing its relevance in the AI era. Bears focus on overreliance on Google search traffic, AI cannibalization, and a high multiple (~50× 2025E EPS), but the author argues these risks are misread—Reddit’s data is increasingly indispensable as authentic UGC becomes scarcer online. The model is capital-light and cash-generative, with long-term potential for 25%+ revenue CAGR and 50%+ FCF/share CAGR through 2030, implying >$12 FCF/share and 15% IRR at current prices. The bull case rests on compounding engagement, stronger advertiser adoption, and scalable AI/data licensing. Core risks include management missteps, overdependence on U.S. traffic, and ad-market cyclicality, but near-term catalysts—steady quarterly beats and new licensing deals—should derisk sentiment. Reddit is positioned as the “trusted human layer” of the internet amid AI content saturation, offering asymmetric upside as the digital world revalues authentic discourse.

BSD Analysis:
Bull: Unique UGC data asset, strong ad-growth runway, AI/data licensing monetization, founder-led turnaround, high FCF scalability. Skeptic: Reliance on Google traffic, AI-generated-content risks, slower DAU growth, premium valuation. Differentiator: Reddit’s cultural ubiquity and authenticity give it a durable moat in an AI-heavy internet, bridging social media and knowledge search.